CHT [CHUNGHWA TELECOM CO] 6-K: Chunghwa Telecom Co., Ltd. S HU EH /
[Chunghwa Telecom Co., Ltd. S HU EH / Shu Yeh Senior Vice President CFO Description 1. Announcement on 2010/11/12 : Chunghwa Telecom to attend investor conference]
ISS [iSoftStone] EFFECT: (Original Filing)
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]
ISS [iSoftStone] EFFECT: .FormData {color: blue; background-color: white; font-size: small; font-family:
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]
TPI [TIANYIN PHARMACEUTICAL] CORRESP: (Original Filing)
[December 13, 2010 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2009 File No. 001-34189 Dear Mr. Wyman: Very truly yours, LESER HUNTER TAUBMAN & TAUBMAN Attorney at Law cc: Dr. Jiang, Tianyin Pharmaceutical Co., Inc. CEO]
TPI [TIANYIN PHARMACEUTICAL] CORRESP: December 13, 2010 Division of Corporate Finance 100
[December 13, 2010 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2009 File No. 001-34189 Dear Mr. Wyman: Very truly yours, LESER HUNTER TAUBMAN & TAUBMAN Attorney at Law cc: Dr. Jiang, Tianyin Pharmaceutical Co., Inc. CEO]
CO [Chinard Bloodrp] SC TO-I/A: (Original Filing)
[_____________HEDULE TO (Amendment No. 2) _____________ (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) _____________ CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 _____________________ ) _____________bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower] [HONG KONG, China, December 13, - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, We believe shareholders will appreciate our simplifiedpital structure.With no further dilution, shareholders will fully enjoy the benefits of our operational accomplishments and robust growth, even on a per share basis.Withl the stakeholders interests now fullyigned, we willntinue to]
CAAS [CHINA AUTOMOTIVE SYSTEMS] 8-K: (Original Filing)
[China Automotive Systems Appoints PricewaterhouseCoopers Zhong Tian CPAs Limited Company as Auditors WUHAN, Hubei, China, December 13, 2010 — China Automotive Systems, Inc. (NASDAQ: CAAS) Schwartz Levitsky Feldman LLP , who resigned Schwartz Levitsky Feldman LLP The appointment of PricewaterhouseCoopers Zhong Tian CPAs About China Automotive Systems, Inc. http://www.caasauto.com Based in Hubei Province, People's Republic of China, China Automotive Systems,] [Form 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 13, 2010 (December 8, 2010) China Automotive Systems, Inc. Delaware 000-33123 33-0885775 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 1 Henglong Road, Yu Qiao Development Zone Shashi District, Jing Zhou City Hubei Province People’s Republic of China (86) 27-5981 8527 ¨]
CO [Chinard Bloodrp] SC TO-I/A: _____________HEDULE TO (Amendment No. 2) _____________ (Rule 14d-100)
[_____________HEDULE TO (Amendment No. 2) _____________ (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) _____________ CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 _____________________ ) _____________bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower] [HONG KONG, China, December 13, - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, We believe shareholders will appreciate our simplifiedpital structure.With no further dilution, shareholders will fully enjoy the benefits of our operational accomplishments and robust growth, even on a per share basis.Withl the stakeholders interests now fullyigned, we willntinue to]
